AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 273: H2687-H2695, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mutafova-Yambolieva, V. N.
Right arrow Articles by Keef, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutafova-Yambolieva, V. N.
Right arrow Articles by Keef, K. D.
Vol. 273, Issue 6, H2687-H2695, December 1997

Adenosine-induced hyperpolarization in guinea pig coronary artery involves A2b receptors and KATP channels

Violeta N. Mutafova-Yambolieva and Kathleen D. Keef

Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, Nevada 89557

The role of P1 purinoceptor subtypes, the adenylyl cyclase (AC) pathway, and ATP-sensitive K+ (KATP) channels in adenosine (Ado)-induced membrane hyperpolarization was investigated in isolated segments of the guinea pig coronary artery using conventional microelectrode techniques. Ado (1-100 µM) elicited concentration-dependent hyperpolarization (half-maximal effective concentration 7.5 ± 0.5 µM) that averaged 28.6 ± 2.9 mV at 100 µM Ado. The A1 selective agonist N6-cyclopentyladenosine (CPA), the A1/A2 agonist 2-chloroadenosine, and the A2a/A2b agonist 5-(N-ethylcarboxamido)adenosine (NECA) each induced glibenclamide (3 µM)-sensitive hyperpolarization at 10 µM. However, the selective A2a-receptor agonists CGS-21680 and N6-[2-(3,5-dimethoxyphenyl)-2-(2-methoxyphenyl]ethyladenosine (10 µM each) were without effect. Responses to CPA and NECA were significantly reduced by the AC inhibitor SQ-22,536 (100 µM). Activation of the AC-adenosine 3',5'-cyclic monophosphate (cAMP)-protein kinase A (PKA) pathway by four additional methods, i.e., 1) forskolin (0.3-1 µM), 2) isoproterenol (0.1-1 µM), 3) combined milrinone (0.4 µM) and rolipram (30 µM), and 4) combined N6-phenyladenosine 3',5'-monophosphate, 8-(6-aminohexyl)aminoadenosine 3',5'-cyclic monophosphate, and the Sp-isomer of 5,6-dichloro-1-D-ribofuranosylbenzimidazole-3',5'-cyclic monophosphothioate (100 µM each), also gave rise to glibenclamide-sensitive hyperpolarization. These results suggest that stimulation of A2b receptors coupled to AC represents the predominant mechanism by which Ado elicits hyperpolarization in this vessel. The ensuing increase in cAMP activates PKA, which then increases the activity of KATP channels. Our results further suggest that KATP channels are an important target for numerous pathways that raise cAMP levels in the coronary artery.

A1 receptors; A2a receptors; glibenclamide; adenylyl cyclase; protein kinase A; adenosine-5'-triphosphate-dependent potassium channel


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Nishiyama, E. W. Inscho, and L. G. Navar
Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F406 - F414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-W. Chen, H.-Y. Chang, and T.-R. Hsiue
Mechanism of adenosine-induced vasodilation in rat diaphragm microcirculation
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2210 - H2217.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. W. Hein, L. Belardinelli, and L. Kuo
Adenosine A2A Receptors Mediate Coronary Microvascular Dilation to Adenosine: Role of Nitric Oxide and ATP-Sensitive Potassium Channels
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 655 - 664.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online